Conclusion: Disclosure of interest: All authors: nothing to disclose E-Posters - ACUTE ISCHEMIC STROKE MANAGEMENT 01.00 - ACUTE ISCHEMIC STROKE MANAGEMENT - 01.01 - ACUTE MANAGEMENT - Neither thrombolysis nor thrombectomy P2131 - ESOC25-2296 MANAGEMENT OF TIA AND STROKE ATTACK RISK STRATIFICATION: EXPERIENCE IN AN ALGERIAN PERIPHERAL HOSPITAL Amina Behiri 1 , Sonia Nouioua 1 , Feroudja Ramdane Cherif 1 1 Department of Neurology El Maham, cherchell, Algeria Background and Aims: The aim of our study is to evaluate the management efficiency for TIA in an Algerian peripheral hospital, and to analyze the risk factors associated with outcome to an ischemic stroke
But the best choice is not always about what sounds more powerful
Patient education should emphasize the limited evidence base, experimental nature of treatment, and importance of ongoing monitoring
Hi there, Go and research a thing called MEGALOBLASTIC ANAEMIA
Purity & third-party testing Every batch of Cagrilintide 5mg is independently analysed by Janoshik Analytical, with a Certificate of Analysis confirming identity and 99% purity available on request
Potent Antinociceptive Effect of Centrally Administered DSIP
